Fujifilm Corporation will invest $40 million to establish a new processing facility to advance viral vector manufacturing and perform cutting-edge research in the field of advanced therapies in the...
AstraZeneca recently acquired Boston-based rare disease specialist, Alexion Pharmaceuticals, in a $39 billion pharmaceutical acquisition deal.
Notably, the deal will be AstraZeneca’s...
Data analytics and business intelligence company Definitive Healthcare continues to expand its footprint in the life sciences space with the acquisition of Monocl, the company announced.
Headquartered...
According to the White House, this strategy would allow Americans to receive the same low prices for prescription medications that are available in other countries.
But many stakeholders have...
Harvard University recently launched Vesigen Therapeutics, which will address the challenges of delivering RNAi, mRNA, and CRISPR technologies to intracellular targets in specific tissues of...
FDA is teaming up with the Critical Path Institute and National Center for Advancing Translational Sciences (NCATS) to launch the CURE Drug Repurposing Collaboratory (CDRC) to evaluate existing drugs...
Three pharmaceutical companies recently formed a partnership to support the discovery and development of next-generation cancer immunotherapies.
For more coronavirus updates, visit...
The lack of rapid and accurate molecular diagnostic testing has impeded the healthcare system’s response to the COVID-19 pandemic. Recently, researchers developed rapid, easy-to-implement, and...
Biopharmaceutical company, Sage Therapeutics, recently announced that it is restructuring its workforce to advance its corporate strategy and pipeline due to the COVID-19 pandemic.
For more...
GlaxoSmithKline (GSK) and Vir Biotechnology recently announced a collaboration to enhance COVID-19 drug discovery through the use of CRISPR and artificial intelligence.
For more coronavirus updates,...
Earlier this week, Roche announced that the FDA approved its CINtec PLUS Cytology as the first biomarker-based triage test for women whose primary cervical cancer screening results are positive for the...
MassBio and Bayer recently announced the Center for Regulatory Excellence, a first-of-its-kind forum that will be open to all startups and academia in the biotech and digital health space to learn from...
HHS launched on Monday the nation’s first Foundry for American Biotechnology for producing technological solutions that help protect against and respond to health security threats, as well as...
The Food and Drug Administration (FDA) and the Federal Trade Commission (FTC) on Monday issued a set of four joint goals to support a competitive US marketplace for approved biological products,...
US Food and Drug Administration (FDA) recently issued six final guidances and draft guidance to advance gene therapy development by clarifying the policy framework for development and...
The Coalition for Epidemic Preparedness Innovations launched three programs to develop vaccines for the coronavirus, including through partnerships with US-based biotechnology companies Inovio...
A PriceWaterhouseCoopers report predicts biotechnology firms will be “extremely active” in merger and acquisition activity and drive pharmaceutical firms’ activity in 2020.
Last year...
2020 will be another blockbuster year for life sciences mergers and acquisitions, according to a recent report from Ernst & Young Health Sciences and Wellness. And companies' interest in...
Nearly a year to the day after acquiring a portion of HIMSS Analytics, data analytics and business intelligence company Definitive Healthcare has announced the acquisition of software analytics firm...
California-based manufacturers of next-generation DNA sequencing (NGS) technology platforms Illumina and Pacific Biosciences of California (PacBio) recently decided to terminate their $1.2-billion...
